In-depth Trade Alerts on Active Stocks: AAPL, KERX, ANPI, GIS, PBY, TLB
Today’s lineup had mixed results in slow trading; PBY surged 8.19% while ANPI dropped nearly 9%.
(EMAILWIRE.COM, June 10, 2009 ) DALLAS, Texas – InvestorSoup.com announces the release of Stock Alerts covering market movers: Apple Inc. (Nasdaq: AAPL), Keryx Biopharmaceuticals Inc. (Nasdaq: KERX), Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI), General Mills Inc. (NYSE: GIS), Pep Boys (NYSE: PBY) and The Talbots Inc. (NYSE: TLB).
The stock alert features the most recent headlines, share price and technical analysis for each covered company. The full alert, as well as other articles, market research and more can be found at InvestorSoup.com
In the Stock Alerts, the author highlights the WWDC conference and Apple’s software and hardware updates:
“Apple Inc. (Nasdaq: AAPL) shares slipped 1.45% to $141.73 this morning. Apple's highly anticipated annual Worldwide Developers' Conference got investors and consumers excited as company executives unveiled everything from a cheaper Mac Air notebook to a new operating system, although CEO Steve Jobs did not put in a much speculated-about appearance. … The company announced several updates to its MacBook line of notebook computers, including price cuts and updates to its Mac operating system, Snow Leopard. … Apple also unveiled its next generation iPhone 3GS, boasting nearly three times faster to download Web page. It comes with a 3-megapixel autofocus camera, voice-control features and a built-in compass. The new iPhone boast of a lower price for the entry-level phone at $99.”
The Stock Alerts author also featured Keryx’s positive midstage safety results for its kidney disease drug Zerenex:
“Keryx Biopharmaceuticals Inc. (Nasdaq: KERX) shares dropped 6.67% in today’s early trading, moving to $1.26. Shares of the New York-based company comfortably secured the green Monday after it reported positive midstage safety results for its kidney disease drug. Shares earlier reached $1.58, their highest point in the past 52 weeks. … Keryx is developing Zerenex, currently in its phase II clinical development stage, as a treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage kidney disease. … The company reported that the candidate met its key safety goals in the study. Meanwhile, the midstage study results suggested that the drug is effective in regulating serum phosphorous levels, though the study is not designed to test for effectiveness. It said it is now in the process of developing a late-stage development program for the drug and is consulting with the Food and Drug Administration.”
Investors can view all of the Stock Alerts and investment articles for free by visiting
http://www.investorsoup.com
Join the fastest growing investor community at
http://www.stockhideout.com
Investor Soup’s Daily Soup is one of the fastest growing small cap blogs in the investment community. Investor Soup strives each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
Investor Soup.com is one of the industry’s newest and rapidly growing small-cap research providers. Investor Soup strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Investor Soup, please visit: http://www.InvestorSoup.com
InvestorSoup.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
The stock alert features the most recent headlines, share price and technical analysis for each covered company. The full alert, as well as other articles, market research and more can be found at InvestorSoup.com
In the Stock Alerts, the author highlights the WWDC conference and Apple’s software and hardware updates:
“Apple Inc. (Nasdaq: AAPL) shares slipped 1.45% to $141.73 this morning. Apple's highly anticipated annual Worldwide Developers' Conference got investors and consumers excited as company executives unveiled everything from a cheaper Mac Air notebook to a new operating system, although CEO Steve Jobs did not put in a much speculated-about appearance. … The company announced several updates to its MacBook line of notebook computers, including price cuts and updates to its Mac operating system, Snow Leopard. … Apple also unveiled its next generation iPhone 3GS, boasting nearly three times faster to download Web page. It comes with a 3-megapixel autofocus camera, voice-control features and a built-in compass. The new iPhone boast of a lower price for the entry-level phone at $99.”
The Stock Alerts author also featured Keryx’s positive midstage safety results for its kidney disease drug Zerenex:
“Keryx Biopharmaceuticals Inc. (Nasdaq: KERX) shares dropped 6.67% in today’s early trading, moving to $1.26. Shares of the New York-based company comfortably secured the green Monday after it reported positive midstage safety results for its kidney disease drug. Shares earlier reached $1.58, their highest point in the past 52 weeks. … Keryx is developing Zerenex, currently in its phase II clinical development stage, as a treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage kidney disease. … The company reported that the candidate met its key safety goals in the study. Meanwhile, the midstage study results suggested that the drug is effective in regulating serum phosphorous levels, though the study is not designed to test for effectiveness. It said it is now in the process of developing a late-stage development program for the drug and is consulting with the Food and Drug Administration.”
Investors can view all of the Stock Alerts and investment articles for free by visiting
http://www.investorsoup.com
Join the fastest growing investor community at
http://www.stockhideout.com
Investor Soup’s Daily Soup is one of the fastest growing small cap blogs in the investment community. Investor Soup strives each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
Investor Soup.com is one of the industry’s newest and rapidly growing small-cap research providers. Investor Soup strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Investor Soup, please visit: http://www.InvestorSoup.com
InvestorSoup.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
Contact Information:
Beacon Equity
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Beacon Equity
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |